Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Array raises $115M in note deal

Array BioPharma Inc. (NASDAQ:ARRY) raised $115 million through the sale of 3% unsecured senior convertible

Read the full 150 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE